133
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Physicochemical compatibility of fluticasone-17-propionate nebulizer suspension with ipratropium and albuterol nebulizer solutions

, &
Pages 599-607 | Published online: 20 Oct 2022

References

  • BalmesJRFineJMChristianD1988Acidity potentiates bronchoconstriction induced by hypoosmolar aerosolsAm Rev Respir Dis1383592849338
  • BeasleyRRaffertyPHolgateST1988Adverse reaction to the non-drug constituents of nebuliser solutionsBr J Clin Pharmacol2528383358893
  • BoeJDennisJHO’DriscollBR2001European Respiratory Society guidelines on the use of nebulizersEur Respir J182284211510796
  • BouletLPLegrisCThibaultL1987Comparative bronchial responses to hyperosmolar saline and methacholine in asthmaThorax4295383438883
  • ClayMMPaviaDNewmanSP1983Assessment of jet nebulizers for lung aerosol therapyLancet2592946136746
  • ElwoodRKHoggJCParéPD1982Airway response to osmolar challenge in asthma (abstract)Am Rev Respir Dis125617065512
  • EschenbacherWLBousheyHASheppardD1984Alteration in Osmolality of inhaled aerosols cause bronchoconstriction and cough, but absence of a permanent anion causes cough aloneAm Rev Respir Dis129211156696320
  • Fachinformation2004aFlutide® “ready to go“ 0.5 mg/2.0 mL Suspension, Flutide® forte “ready to go” 2.0 mg/2 mL Suspension, 08/2004 GlaxoSmithKline GmbH and Co. KG, München.
  • Fachinformation2004bSultanol® “ready to go”, Sultanol® forte “ready to go”, Sultanol® inhalation solution, 04/2004 GlaxoSmithKline GmbH and Co. KG, München.
  • Fachinformation2005Atrovent® LS, 04/2005 Boehringer Ingelheim Pharma GmbH and Co. KG, Ingelheim am Rhein.
  • FineJMGordonTThompsonJE1987The role of titratable acidity in acid aerosol-induced bronchoconstrictionAm Rev Respir Dis135826303551704
  • GronbergSMagnussonPBladhN2001Chemical Compatibility of Budesonide Inhalation Suspension (Pulmicort™) with other nebulization productsAm J Respir Crit Care Med163A588
  • JacobsonGAPetersonGM1995Stability of ipratropium bromide and salbutamol nebuliser admixturesInt J Pharm Pract316973
  • KaminWSchwabeAKrämerI2006Inhalation solutions-which one are allowed to be mixed? Physico-chemical compatibility of drug solutions in nebulizersJ Cyst Fibros542051316678502
  • MannJSHowarthPHHolgateST1984Bronchoconstriction induced by ipratropium bromide in asthma: relation to hypotonicityBMJ2894696235889
  • McKenzieJGronbergSCruz RiveraM2002Budesonide inhalation suspension can be nebulized with solutions containing albuterol sulphate [poster]Chest122Suppl183S
  • McKenzieJECruz-RiveraM2004Compatibility of budesonide inhalation suspension with four nebulizing solutionsAnn Pharmacother389677215084687
  • NagtegaalJEDe JongADe WaardWJ1997Formulation and shelf life of two solutions for inhalationZiekenhuisfarmacie13239
  • O’CallaghanCMilnerADSwarbrickA1989Paradoxical bronchoconstriction in wheezing infants after nebulised preservative free isoosmolar ipratopium bromideBMJ299143334
  • Pharmacopoeia Europea20055th Ed. Deutscher Apotheker Verlag, Stuttgart, Govi-Verlag-Pharmazeutischer Verlag, Eschborn.
  • SchoeffelRGAndersonSDAltounyanRE1981Bronchial hyperreactivity in response to inhalation of ultrasonically nebulised solutions of distilled water and salineBMJ2831285876794821
  • SchwabeAKrämerIKaminW2005Physico-chemical compatibility of ipratropium, albuterol and fluticasone nebulizer solutionsDPhG-Jahrestagung, Mainz, 05.-08.10.2005; Abstract ISBN 3-00-016844-3.
  • SmaldoneGCMcKenzieJCruz RiveraM2000aEffect of nebulizer volume on drug delivery: budesonide inhalation suspensionAm J Respir Crit Care Med161A36
  • SmaldoneGCMcKenzieJCruz RiveraM2000bBudesonide inhalation suspension is chemically compatible with other nebulizing formulations [abstract]Chest11898S
  • van den BemtPMLAde BijlGLangenMCJ1997Validation of two methods for the analysis of salbutamol/ipratropium inhalation fluidZiekenhuisfarmacie13925